CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis

Annals of the Rheumatic Diseases

Volumn 71, Issue 1, 2012, Pages 99-107

  Tsushima, Hidetoshi ^a   Okazaki, Ken ^a   Hayashida, Mitsumasa ^a   Ushijima, Takahiro ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 2; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGENASE 3; INTERLEUKIN 1BETA; MESSENGER RNA; STROMELYSIN;

ADENOVIRUS; AGED; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SYNOVIOCYTE;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROCOLLAGEN N-ENDOPEPTIDASE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TISSUE CULTURE TECHNIQUES; YOUNG ADULT;

EID: 82955173831     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200061     Document Type: Article

References (40)

1. Farahat MN, Yanni G, Poston R, et al. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5. (Pubitemid 24019143)
2. Benito MJ, Veale DJ, FitzGerald O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005;64:1263-7. (Pubitemid 41206240)
3. Otero M, Goldring MB. Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res Ther 2007;9:220.
4. Bondeson J, Blom AB, Wainwright S, et al. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010;62:647-57.
5. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991;5:1538-52. (Pubitemid 21906060)
6. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002;365:561-75. (Pubitemid 34864439)
7. Pope RM, Lovis R, Mungre S, et al. C/EBP beta in rheumatoid arthritis: correlation with inflammation, not disease specificity. Clin Immunol 1999;91:271-82. (Pubitemid 29250213)
8. Nishioka K, Ohshima S, Umeshita-Sasai M, et al. Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPbeta and C/ EBPdelta, in rheumatoid synovium. Arthritis Rheum 2000;43:1591-6. (Pubitemid 30452480)
9. Massaad C, Paradon M, Jacques C, et al. Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1beta. Role of C/EBP factors. J Biol Chem 2000;275:22686-94. (Pubitemid 30646150)
10. Thomas B, Berenbaum F, Humbert L, et al. Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin- 1beta in articular chondrocytes. Eur J Biochem 2000;267:6798-809.
11. Greenwel P, Tanaka S, Penkov D, et al. Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol Cell Biol 2000;20:912-18. (Pubitemid 30044228)
12. Gutierrez S, Javed A, Tennant DK, et al. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 2002;277:1316-23. (Pubitemid 34968885)
13. Okazaki K, Li J, Yu H, et al. CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. J Biol Chem 2002;277:31526-33. (Pubitemid 34968954)
14. Raymond L, Eck S, Mollmark J, et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol 2006;207:683-8. (Pubitemid 43668231)
15. Hayashida M, Okazaki K, Fukushi J, et al. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis. Arthritis Rheum 2009;60:708-16.
16. Malfait AM, Liu RQ, Ijiri K, et al. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 2002;277:22201-8. (Pubitemid 34967185)
17. Song RH, Tortorella MD, Malfait AM, et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007;56:575-85.
18. Okada Y, Shinmei M, Tanaka O, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
19. Okada Y, Takeuchi N, Tomita K, et al. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-53. (Pubitemid 19201961)
20. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986;261:14245-55. (Pubitemid 17196334)
21. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 1988;267:211-16. (Pubitemid 19001025)
22. Blom AB, van Lent PL, Libregts S, et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007;56:147-57. (Pubitemid 46106187)
23. Yamanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
24. Lohmander LS, Brandt KD, Mazzuca SA, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum 2005;52:3160-7. (Pubitemid 41447098)
25. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
26. Mort JS, Buttle DJ. The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mol Pathol 1999;52:11-18. (Pubitemid 29064257)
27. Sztrolovics R, Alini M, Roughley PJ, et al. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 1997;326:235-41. (Pubitemid 27386941)
28. Sakaue H, Konishi M, Ogawa W, et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev 2002;16:908-12. (Pubitemid 34408540)
29. Hirai Y, Radisky D, Boudreau R, et al. Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta. J Cell Biol 2001;153:785-94. (Pubitemid 34286110)
30. Oelgeschläger M, Nuchprayoon I, Lüscher B, et al. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 1996;16:4717-25. (Pubitemid 26272125)
31. Akira S, Isshiki H, Sugita T, et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-906.
32. Mudgett JS, Hutchinson NI, Chartrain NA, et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998;41:110-21. (Pubitemid 28041929)
33. Marini S, Fasciglione GF, Monteleone G, et al. A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities. Clin Biochem 2003;36:295-304. (Pubitemid 36700453)
34. Smeets TJ, Barg EC, Kraan MC, et al. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 2003;62:635-8. (Pubitemid 36760560)
35. Vankemmelbeke MN, Holen I, Wilson AG, et al. Expression and activity of ADAMTS-5 in synovium. Eur J Biochem 2001;268:1259-68. (Pubitemid 32231878)
36. Bau B, Gebhard PM, Haag J, et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002;46:2648-57. (Pubitemid 36118928)
37. Hirata M, Kugimiya F, Fukai A, et al. C/EBPbeta promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS ONE 2009;4:e4543.
38. Tsuchimochi K, Otero M, Dragomir CL, et al. GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes. J Biol Chem 2010;285:8395-407.
39. Thirunavukkarasu K, Pei Y, Wei T. Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter. Mol Biol Rep 2007;34:225-31. (Pubitemid 47624284)
40. Kamekura S, Kawasaki Y, Hoshi K, et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006;54:2462-70. (Pubitemid 44205006)